(Q35130911)

6 August 2017

1 reference

title

Azathioprine: current status and future considerations (English)

1 reference

6 August 2017

0 references

Rokea A El-Azhary

1

1 reference

6 August 2017

language of work or name

1 reference

1 May 2003

1 reference

International Journal of Dermatology

6 August 2017

published in

1 reference

6 August 2017

volume

42

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

335-341

1 reference

Immunosuppression-back to the future

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Pharmacogenetics of cancer therapy: getting personal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

A pharmacogenetic basis for the safe and effective use of azathioprine and other thiopurine drugs in dermatologic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Azathioprine for atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Nuclear DNA diversity in worldwide distributed human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Treatment With Immunosuppressive and Disease Modifying Drugs During Pregnancy and Lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

The use of azathioprine in severe adult atopic eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Polyarteritis nodosa in Arab children in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Azathioprine-induced drug fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Inhibition of human thiopurine methyltransferase by furosemide, bendroflumethiazide and trichlormethiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Thiopurine methyltransferase alleles in British and Ghanaian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Purine substrates for human thiopurine methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Polymorphism of the thiopurine S-methyltransferase gene in African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Improved methods for determining the concentration of 6-thioguanine nucleotides and 6-methylmercaptopurine nucleotides in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Monitored high-dose azathioprine treatment reduces acute rejection episodes after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Clinical consequences of the polymorphism of azathioprine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Psoriasis and bullous pemphigoid treated with azathioprine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

Clinical implications of thiopurine methyltransferase--optimization of drug dosage and potential drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01823.X

10.1046/J.1365-4362.2003.01823.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference